Is there resistance to fusidic acid?
Fusidic acid is generally prone to drug resistance. The detailed analysis is as follows:
Fusidic acid is a steroidal antimicrobial agent with both bacteriostatic and bactericidal activity. Clinically, it is used to treat infections caused by Gram-positive bacteria, such as osteomyelitis, sepsis, and endocarditis. Common formulations include creams, suspensions, and eye drops. Drug resistance refers to the tolerance developed by microorganisms, parasites, or tumor cells against chemotherapeutic agents. Once resistance occurs, the therapeutic efficacy of the drug significantly decreases. Prolonged use of fusidic acid may lead to drug resistance, primarily because repeated administration or insufficient treatment duration fails to eliminate bacteria promptly, thereby facilitating the development of resistant strains.
If fusidic acid is required, it should be used under the guidance of a physician; blind selection or self-adjustment of dosage is strongly discouraged. This drug is mainly excreted via bile. Therefore, patients with hepatic insufficiency, biliary diseases, or biliary obstruction should have their liver function closely monitored during treatment to avoid adverse effects. Additionally, if combination therapy is needed, medical advice should be sought.